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A B S T R A C T C T
Gold nanoparticles (AuNPs) have arisen a lot of interest in the clinical realms of nanomedicine. Despite the large ad-
vances made in cancer research using AuNPs, their use in tissue engineering and regenerative medicine (TERM) is still in
its infancy. Herein, it is discussed the properties, functionalization, and emerging use of AuNPs as a multifunctional and
multimodal platform for drug delivery, phototherapy, diagnostic and cell imaging purposes. Moreover, the recent reports
related to the ability of AuNPs to enhance stem cell differentiation for bone tissue engineering, to enhance the mechanical
and adhesive properties of scaffolds and surface topography to guide cell behaviors are addressed.
© 2016 Published by Elsevier Ltd.
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1. Introduction
Tissue Engineering and Regenerative Medicine (TERM), a mul-
tidisciplinary field including engineering, biology, and medicine, has
been promising to develop viable therapeutic alternatives to organ and
tissue transplantation. TERM thus holds great attention to tackle the
clinical tasks by repairing, replacing or regenerating damaged tissues
with functional engineered counterparts [1–3].
The human organs and tissues are composed of cells that can grow,
proliferate and differentiate into desired cell type onto the 3D scaf-
fold materials. In TERM, the use of stem cells such as mesenchymal
stem cells and adipose-derived stem cells to differentiate into different
cell lineages such as chondrocytes (cartilage cells), osteoblasts (bone
cells), adipocytes (fat cells) have been considered as a great choice and
continue to be significantly used [4]. However, to date, the limitations
encountered for the regeneration of artificial tissue (bone, cartilage,
skin, cardiac/skeletal muscle, nerve) are mainly due to poor mechani-
cal and cell adhesive properties of scaffold, inefficient cell growth and
differentiation at the defect site, as well as unstable growth factors to
stimulate cell growth [5,6].
TERM has the willing to develop a system that will be able to en-
hance the regeneration of the tissue, by it means a system that will
deliver growth factors and improve mechanical properties of scaffold,
providing to the cells a suitable environment to differentiate. Within
this challenge in mind, researchers attempt to introduce new scientific
and technology concepts to revolutionize this clinical realm. To date,
nanotechnology has emerged as a promising tool and has made a ma-
jor impact in modern science [7,8]. In mid-1990 s, scientists start to
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actively exploit the remarkable features of nanotechnology for vari-
ous biological and medical applications and since the advances in nan-
otechnology for medicine continue to grow with the development of
novel biomedical strategies [9,10]. With the aim to improve the pre-
sent progress in TERM, a tremendous number of studies have success-
fully exploited polymeric and inorganic nanoparticles (NPs) [11–14].
Among those, gold nanoparticles (AuNPs) are one of the most promis-
ing and explored tools in nanomedicine. AuNPs have been widely
used as therapeutic agents (drug delivery system [15], photothermal
therapy [16]), diagnosis agents [17] and imaging agents [18,19]. Their
nanoscale size, which meets the dimension of biological compounds,
their easy preparation, high surface area, easy functionalization make
them particularly interesting to accomplish the duties related to
TERM. Besides, they present remarkable physicochemical properties,
which are different from those of the corresponding bulk materials,
and make them unique compared to classical NPs such as liposomes,
polymeric NPs, and protein-based NPs. These physicochemical prop-
erties derive from the localized surface plasmon resonance (LSPR), a
collective oscillation of the conduction electrons that typically occurs
in the visible to near-infrared (NIR) region spectrum and can be easily
detected by NIR-UV-visible spectrometry or even by eye [20]. There-
fore, the mission of AuNPs in TERM is to act as a multimodal tool
in order to enhance scaffold properties, cell differentiation and intra-
cellular growth factor delivery (Fig. 1), while monitoring in real-time
cellular events.
Despite the large advances made in cancer research using AuNPs,
their use in TERM is still in its infancy. However, their potential
in this area is away analogous to cancer theranostics approaches.
Hence, the asset of exploiting AuNPs as promising multimodal tools
for TERM will be discussed while supporting some new trends in the
cancer field. Firstly, it is reported the preliminary strategies for tun-
ing the properties of AuNP’s, by means of synthesis, functionalization
and cell-AuNPs interactions, which are requested for the preparation
http://dx.doi.org/10.1016/j.cossms.2016.03.006
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Fig. 1. Scheme representing the importance of introducing AuNPs in TERM realm. TERM combines three elements: scaffold, cells and bioactive molecules for engineered or repaired
tissue. The addition of AuNPs in each element aims to enhance scaffold features (mechanical, adhesive), cell differentiation and intracellular delivery of bioactive molecules in order
to bring an ideal microenvironment for the regeneration of the damaged tissue.
of a biocompatible nanomaterial. Then, the recent works using AuNPs
as individual or multifunctional tool for drug delivery, diagnosis and
imaging in TERM, specifically related to stem cell research is
overviewed. Finally, the recent advances using AuNPs to enhance
stem cells differentiation for bone tissue engineering, and to improve
mechanical and adhesive properties, and favored nanostructures of
scaffolds to guide cell behavior will be addressed.
2. Preparation and properties of AuNPs
2.1. Synthesis routes
The synthesis routes of AuNPs have been widely developed in or-
der to control their shape and size, thus leading to diverse proper-
ties and multimodal applications. To date, numerous methods have
been reported for preparing a wide variety of shapes (Fig. 2) such as
nanospheres [21,22], nanorods [23,24], nanoplates [25], nanodumbells
[26], nanostars [27,28] and nanocages [29]. Wet-chemical synthe-
sis of AuNPs is the most common method and is carried out of
presence of a stabilizer, which can bind to the atom exposed at the
AuNPs surface. This capping agent allows stabilization and prevents
uncontrolled growth and aggregation of the NPs. For more details
regarding the processes to control AuNPs synthesis, we highly en-
courage to read the following reviews [30,31]. Here, we will briefly
describe the «classical» methods to prepare spherical AuNPs. Typi-
cally, the AuNPs synthesis approach implies both the use of a reduc-
ing agent that serves to reduce Au3+ to Au atoms and a stabilizer (cap-
ping agent) to maintain colloidal stability. The synthesis of spherical
NPs have been developed by Turkevish [32] in 1951 and since has
been employed in a multitude of studies. NPs with a size of 20 nm
were prepared with citric acid that acts both as the reducing and sta-
bilizing agents. Later [33], the size-controlled NPs were developed
by varying the ratio gold salt and sodium citrate. On the other hand,
the preparation of anisotropic NPs such gold nanorods (AuNRs) re-
quires the use of a template, mostly surfactant, and the most estab-
lished and efficient process to prepare high yield is based on the seed-
growth method [34,35]. Firstly, gold seed are prepared by reduction
of chloroauric acid salt (HAuCl4) solution by sodium borohydride in a
Fig. 2. Scheme representing diverse AuNPs shape.
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cetyltrimethyl ammonium bromide (CTAB) aqueous solution. Subse-
quently, the seed is added to a gold “growth” solution in presence of
CTAB, silver nitrate and ascorbic acid (weak reducing agent).
As aforementioned, the synthesis of AuNPs implies the reduction
of gold ions and the use of a charged chemical that maintains the
colloidal stability of the NPs via repulsive force. However, AuNPs
exhibit low stability and biocompatibility in biological environment.
Therefore, the concept of “green synthesis”, using biocompatible com-
pounds, has been considered as an alternative to conventional methods
for preparing AuNPs. Taking into account that some sugars are able to
reduce metal ions [36,37], polysaccharides, biomaterials with favor-
able properties for tissue engineering scaffolding [38–40] have also
been used for the preparation of stabilized and controlled-size NPs
[41]. Polysaccharides are natural polymers composed of multiple sac-
charides and are extracted from renewable resources such as plants,
animals and microorganisms, making them environmental friendly to
be used in chemistry. Moreover, they can be negatively-charged such
as gum arabic, gellan gum and hyaluronic acid or positively charged
as chitosan, leading to the stabilization of AuNPs in aqueous solution.
On this purpose, chitosan (Cht) [42–44], gum arabic (GA) [45,46],
gellan gum (GG) [47,48], guar gum [49], xanthan gum (XG) [50],
and gum karaya [51] have been employed to induce the formation
of highly stable and biocompatible spherical AuNPs. As an example,
Wu et al. have developed a facile method to prepare 21.1 ± 4.6 nm
spherical AuNPs with fcc structure in 4 h at 55 °C of reaction using
GA [45]. The authors observed that by means of increasing the tem-
perature from 25 to 75 °C the formation rate can be modulated but it
does not affect the optical properties and size of the as-prepared NPs.
However, the GA/Au3+ ratio has revealed to be a determinant parame-
ter to obtain uniform particles with good stability in salt conditions.
In another study, AuNPs were prepared with GG at high temperature
[48,47]. The GG-coated NPs functionalized with sophorolipids have
shown to be highly stable in a wide range of pH and ionic strength and
no cytotoxic, making them great candidate as drug delivery carrier. In
general, this approach led to the formation of spherical NPs. However,
the formation of other types of shape has been reported [43,52]. Potora
et al. have observed that reducing HAuCl4 with high molecular weight
chitosan flakes at 100 °C generated the formation of 18 nm AuNPs
self-assembled in branched chains. Whereas, 27 nm single spherical
AuNPs and gold nanoplates with lateral size from 40 to 200 nm were
prepared at 50 °C and at 10 °C, respectively [43]. The authors hypoth-
esized that low temperature decreases the number of seed during the
nucleation step and that the amino group of Cht may interact preferen-
tially with some facets of AuNPs, yielding a small number of NPs of
large size and anisotropic shape. The Table 1 sums up the shape and
size of AuNPs during the reduction of HAuCl4 at elevated tempera-
ture by diverse polysaccharides and their potential applications. It can
be noticed that other materials studied suitable for tissue engineering
have also demonstrated the ability to prepare AuNPs in one-step syn-
thesis as reducer/stabilizer such as silk fibroin [53], gelatin [54,55], as
well as a stabilizer such as collagen [56,57].
2.2. Surface engineering of AuNPs
Surface modification of the AuNPs is almost ineluctable to make
them suitable for bio-applications [58]. Several strategies of coating
have been considering taking into account the initial surface chem-
istry of the particles, their final application with the common objec-
tives to make them biocompatible, stable in physiological media, but
as well enable them to carry active molecules for drug delivery, diag-
nosis, imaging and therapy purposes. In addition, the surface modifi
Table 1.
«Green synthesis» of AuNPs using polysaccharides.
Polysaccharide
Temperature
of synthesis
AuNPs
characteristics Studies Ref.
Chitosan 55 °C for
2 h
Shape: spherical
Mean size: 13 nm
N/A [41]
Chitosan Heating for
15 min
Shape: spherical
Mean size:
20–30 nm
Drug delivery [42]
Chitosan flakes
(high
molecular
weight)
10 °C
50 °C
100 °C
Gold nanoplates
with lateral size
from 40 to 200 nm
27 nm single
spherical AuNPs
18 nm AuNPs self-
assembled in
branched chains
Signal amplifier of
Surface-enhanced
Raman scattering
[43]
Low molecular
chitosan
oligosaccharide
25 °C
at pH: 2.9
Shape: spherical
Average size:
115.21 ± 16.87 nm
In vitro cytotoxicity
on Human
fibroblasts cells
Dose-dependent
effect. Cytotoxic at
a concentration of
62.5 μg/ml
[44]
Gum Arabic 25 °C
40 °C
55 °C
75 °C
For 4 h
Shape: spherical
Mean size:
21.1 ± 4.6 nm
Increasing the
reaction T°C
increased the
formation rate
N/A [45]
Gum Arabic Reflux Shape: spherical
Average size:
15–20 nm
X-ray computing
tomography contrast
agent
[46]
Gellan Gum High T°C Shape: spherical
Mean size: 14 nm
Cellular uptake
Subacute oral
cytotoxicity
Drug delivery
[47]
[48]
Guar Gum 80 °C for
160 min
Shape: spherical
Mean size: 6.5 nm
Ammonia sensor [49]
Xanthan Gum 80 °C for
3 h
Shape: spherical
Average size:
15–20 nm
Drug delivery [50]
Gum Karaya 90 °C for 1
hour
Shape: spherical
Average size:
20–25 nm
Drug delivery [51]
cation has been considered to minimize non-specific binding to bi-
ological components, by means of escaping to the clearance by the
reticulo-endothelial system (RES) and enhancing the circulating time
in order the enhance their accumulation in organ/tissue (e.g. tumor).
Among those strategies, ligand exchange, encapsulation, non-bonding
approach are the most common approaches (Fig. 3).
2.2.1. Ligand exchange
Due to the high affinity with thiol providing a strong S Au bond,
AuNPs are coherently functionalized on their surface with compounds
containing sulfur group. Typically, the modification occurs when a
large excess of thiolated compounds is used, thus allowing ligand ex-
change. Various compounds have been anchored to AuNPs depend-
ing on the final applications [58,59]. Biological moieties such pep-
tides, proteins, antibodies, oligonucleotides are used as probes for spe-
cific recognition of target or as therapeutic molecules, whereas poly-
meric compounds such as polyethylene glycol (PEG) are used to in-
crease the circulating life and prevent non-specific adsorption. For
example, oligonucleotides-anchored AuNPs have been prepared by
addition of single-strand (ss)-thiolated-DNA to the NPs solution for
few hours [60]. This process led to successfully cover the AuNPs
surface with high number of DNA, making them very attractive for
gene therapy [61] and diagnosis (Fig. 3A.1) [17]. On the
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Fig. 3. Main AuNPs surface engineering strategies. (A) Thiol-gold affinity (1) schematic of nanoflare structure and function consisting on a monolayer of DNA probes adsorbed to
the surface of a 13-nm spherical AuNPs. Reprinted from [17]. (2) Schematic representation of polythiol PEG-based copolymers protected AuNPs. Reprinted from [64]. Copyright
2013, with permission from Elsevier (B) Core-shell structure (1) The QR’s morphology. (A) Schematic of a QR. QRs are composed of hollow mesoporous silica shells (HS, gray)
hosting both AuQDs (red) and AuNPs (yellow). (B and C) Bright-field TEM. (Scale bar, 0.2 μm and 20 nm.) (D) Higher-magnification bright field TEM image. (Scale bar, 20 nm.)
(E) HAADF-STEM image. (Scale bar, 20 nm.) (F) Higher magnification HAADF-STEM image of a QR silica shell showing the AuQDs (red arrows). (Scale bar, 20 nm.) . Reprinted
from[72] (2) TEM image of AuNR@PNIPAM microgels. Reprinted from [69]. Copyright 2014, with permission from Elsevier (C) (1) AuNR coating and rhodhamine wrapping
in different types of polymer layers. Reprinted with permission from [73]. Copyright 2012 American Chemical Society(2) LbL process to produce AuNPs for co-delivery of DNA
and siRNA (SS37: disulfide-containing poly(amido amine) and 447: hydrolytically degradable poly(beta-amino ester)) . Reprinted from[77]. Copyright 2014, with permission from
Elsevier (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
other hand, functionalization of AuNPs with thiolated-PEG has been
widely investigated to minimize non-specific binding and to increase
long circulating time in the RES [62,63]. Lui et al. have reported the
functionalization of AuNPs with a thiol-based multidatente PEG via
free radical polymerization (Fig. 3A.2) [64]. The synthesized NPs ex-
hibited good biocompatibility and have shown better colloidal stabil-
ity as compared to AuNPs anchored with mono-thiol PEG. Moreover,
after in vivo assays, they observed that organs biodistribution can be
tuned by playing with the PEG ligands content. Whereas higher PEG
content induced a lower accumulation of the NPs in the liver, longer
retention in the blood and higher uptake in the tumors, the AuNPs
coated by ligands with relatively lower PEG fraction had shown lower
accumulation in the spleen.
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2.2.2. Encapsulation
Encapsulation, also defined as a core-shell structure, implies em-
bedding AuNPs within an inorganic or polymeric shell [65]. Addition-
ally, the shell may exhibit functional group, allowing further modifi-
cation with active molecules. That method is widely used to develop
NPs-based drug delivery system, increasing greatly the drug payload
and involves a multitude of possibilities with the AuNPs as core and
materials such as silica [66], silver [67], polyalinine [68], poly(N-iso-
propylacrylamide) [69], chitosan [70], as shell. This approach leads
as well to the preparation of highly monodisperse and homogeneous
morphological structure and chemical composition. Silica shell around
spherical, rods-like NPs have been prepared since this inorganic ma-
terials exhibit good biocompatibility and biodegradability and higher
cell uptake [71]. Recently, M. Stevens ́ group has reported the encap-
sulation of 2 nm gold quantum dots and NPs (>2 nm) inside a protec-
tive and stabilizing hallow mesoporous silica shell as shown in Fig.
3B.1 [72]. In their design, gold-silica rattle (quantum rattle (QR)) al-
lowed to stabilize gold quantum dots in the biological environment,
while maintaining their photonic activity and paramagnetism. Such
hybrid materials have shown interesting properties as platform for
multimodal imaging and therapy. In another work, chitosan, a bioma-
terial widely studied in tissue engineering scaffolding has received a
great interest to coat NPs, due as well to its hydrogel properties. Guo
et al. have developed a multifunctional drug nanocarrier based on chi-
tosan-modified AuNRs for real-time cell imaging, and near-NIR ther-
motherapy [70]. AuNRs were encapsulated within chitosan (Cht) ma-
trix via a non-solvent-aided counterion complexation method. The Cht
was then cross-linked with glutaraldehyde and the final Cht-AuNR
nanosphere has found to have good biocompatibility and stability.
Another interesting approach is the use of smart polymers, i.e.
polymers exhibiting reversible response features toward the use of ex-
ternal stimuli such temperature and pH. Poly(N-isopropylacrylamide)
(PNIPAM), for example, undergoes a volume phase transition around
32 °C. At room temperature, PNIPAM exhibits a random coil con-
formation in aqueous solution, whereas at temperature above 32 °C it
separates from the solution. PNIPAM has been embedded around par-
ticles to prepare thermo-responsive nanomaterials for diagnosis. Core-
shell structure of gold nanorods covered by a cross-linked PNIPAM
microgels [69] have been prepared by seed-precipitation polymeriza-
tion method using butenoic acid modified AuNRs as seeds (Fig. 3B.2).
Tuning the temperature from 20 to 48 °C, and vice-versa, has pro-
voked a reversible shift of the LPB from 745 to 804 nm, leading to the
development of a monodisperse thermo-responsive plasmonic nanos-
tructure.
2.2.3. Non-covalent surface modification
Non-covalent surface modification of NPs has been widely ex-
ploited and it is mainly based on electrostatic interactions. The Layer-
by-Layer (LBL) method consists on the alternative deposition of an-
ionic and cationic polyelectrolytes on the NPs surface, resulting to
the formation of onion-like multilayers structure, where charged tar-
get molecules can also been incorporated. On this purpose, a multi-
ple strategy has been developed using charged compounds such as
polyelectrolytes [73–75], oligonucleotides [76–78], proteins [79], an-
tibodies [80]. Multilayer of poly-acrylic acid/poly-allylamine has been
used to entrapped rhodamine to develop a model for drug photo-
release (Fig. 3C.1) [73]. Recently, Bishop et al. have developed a
proof-of-concept multi-layer AuNPs to co-release DNA and SiRNA
through LBL biodegradable polymers coating strategy (Fig. 3C.2)
[77]. Different types of polymers have been studied such as poly(eth
ylenimine) (PEI), poly(amido amine) (SS37) and poly(beta amido es-
ter) (447). In their design, AuNPs were alternatively coated with PEI/
DNA/PEI or SS37 or 447/DNA or siRNA/PEI or 447. The reported
NPs led to exogeneous DNA expression and siRNA-mediated knock-
down. Likewise, a polystyrene sulfonate/polyallylamine bilayer has
been deposited around AuNRs to develop a biocompatible nanocarrier
that can be loaded and deliver small interfering RNA (siRNA) against
LDS1 in order to induce differentiation of human mesenchymal stem
cells [81].
2.3. Cytotoxicity and cells-AuNPs interactions
One of the requirements to fulfill the objectives of TERM is to use
a non-toxic system for cells, i.e., a bioinert or biodegradable system.
Cytotoxicity studies of AuNPs need to be carefully assessed for their
use in biomedicine [82]. Therefore, in vitro assays and in vivo ani-
mal models to determine biocompatibility of AuNPs have been con-
sidered before further use in human. While it is stipulated that gold
core is inert, the literature remained still unclear and unreliable on the
effect of AuNPs within cells. Typically, cytotoxicity may be related
to the size [83,84], concentration [85], and surface chemical composi-
tion [86,87], and the cell type [88]. Naha and colleagues have studied
the cytotoxicity of a library of NPs with different shapes (spheres and
rods), surface coatings (e.g. citrate, silicate, lipoprotein, polymaleic
acid, polyethylene glycol and DNA) and sizes (in a range from 3 to
145 nm) [86]. The particles were cultured in three types of mammalian
cells lines, namely human fibroblasts (BJ5ta9), human colon epithe-
lial (C2BBe1) and mouse macrophages. Based on the MTS assay and
cell cytoskeleton analysis, it was reported that after 1 h of cell ex-
posure, none of NPs exhibited a significant decrease of cell viabil-
ity, whereas after 24 h, it was observed that AuNRs and DNA-coated
AuNPs can induce cytotoxicity. In their research, they concluded that
surface agent was the leading cause of cytotoxicity over the cellular
uptake capacity.
AuNPs-mediated cytotoxicity is usually dose-dependent and as-
sociated to membrane damage, cell contents leakage and reactive
oxygen species (ROS) generation. For example, high level of ROS
may induce DNA damage or affect mitochondrial viability, leading
to cell apoptosis [89,90]. Un-modified and commercially AuNRs
(52 nm × 25 nm) have been cultured for 4 h in A549 cells, a human
lung adenocarcinoma cell line with a range of concentration between
2.5 and 15 μg/mL [91]. Upon NPs internalization, the cell membrane
was damaged, resulting in lactase dehydrogenase (LDH) leak. In ad-
dition, the high levels of ROS production have been identified as the
main cause of cytotoxicity. However, in oncology in which cancer cell
death is intentionally induced, damaging cell cytoskeleton could be a
good strategy. Targeting mitochondria with AuNPs led to disrupt the
mitochondrial membrane. The intermembrane cytochrome c was re-
leased to the cytosol, which activated the caspase signaling pathway
and generated breast cancer apoptosis [92].
In order to obtain more consensual outcomes, few reports focused
on providing standardized in vitro protocols [84,85]. Recently, Soe-
nen et al. have described a multiparameter strategy to evaluate the cy-
totoxicity of 14 nm poly(methacrylic acid)-coated AuNPs with 4 nm
Au core [85]. NPs at 10, 20, 50, 100, 200 and 500 nM have been in-
cubated for 4 and 24 h with three different cell lines: C17.2 neural
progenitor cells, primary HUVECs and rat PC12 cells. To better un-
derstand the effect of the NPs on the cells behavior, different but
complementary in vitro assays such as cell viability, ROS, cell mor-
phology, cytoskeleton architecture and cell functionality have been
assessed. All together, the assays have shown that the two highest
concentrations induced cell apoptosis, mostly through the production
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of ROS. However, even though no decrease of cell viability was de-
tected at lower concentrations, the best condition was 10 nM. Only at
this concentration, all cell functions were preserved. That study high-
lighted the importance of merging diverse assays to insure good cell-
NPs interaction.
To prevent those deleterious health effects in which surface chem-
istry has been identified as a dominant factor, a great effort have
emerged to prepare AuNPs through green synthesis strategy. Most of
the reports have claimed a good biocompatibility of the NPs. Xanthan
gum-stabilized AuNPs have shown to be no cytotoxic to A549 hu-
man lung cancer cells for 48 h [50], whereas Cht-AuNPs have shown a
dose-dependent cytotoxicity against human fibroblasts cells, resulting
from a cell viability decrease at concentrations higher than 62.5 μg/
mL [44].
3. AuNPs for multimodal applications
The development and the use of multimodal NPs able to act at the
same time as therapeutic, diagnostic and imaging agents are the cut-
ting-edge research in which TERM may benefit. We can cite the re-
cent successful development of gold-silica quantum rattles (Fig. 3B1)
that hold a variety of functionalities including drug delivery, pho-
tothermal therapy in combination with three imaging modalities such
as NIR fluorescence, photoacoutic and magnetic resonance imaging
[72]. In this context, AuNPs can be seen as a potential nanotool (Fig.
4) for multimodal applications since they enable: (i) to deliver biologi-
cal and chemical active molecules in a spatial and temporal-manner to
improve therapeutic outcomes, (ii) to diagnose cells proliferation and
differentiation, and (iii) to label cells and tracking of implanted cells.
Fig. 4. Scheme representing the use of AuNPs to control and track cell behavior as a drug nanocarrier, as a nanoprobe and finally as a contrast agent for implanted cells.
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3.1. AuNPs-based therapy
3.1.1. AuNPs-based drug delivery system
The controlled delivery of active biomolecules in live cells or or-
ganic tissues to improve therapeutic outcomes is one of major re-
search area in biomedicine. However, the intracellular release of such
compounds in the area of lesion remains an important challenge, es-
pecially due to the lack of physiological solubility of the molecules
and a low cell membrane permeability. Thereby, high-doses are usu-
ally administrated, likely involving undesired side effects. The ratio-
nale behind the loading of bioactive molecules in nanomaterials or at-
tached to their surface is a breakthrough that allowed delivering in
a spatial-and temporal-manner the intended molecules directly inside
cells [93,94]. AuNPs have gained attention as drug delivery system
(DDS) since they exhibit high-density surface allowing high yield lig-
and anchorage, facile transmembrane delivery, targeting cellular de-
livery and controlled intracellular release. In cancer therapy, AuNPs-
based vehicles allow to enhance the in vitro and in vivo therapeutic
activity of diverse chemotherapies such as temozolomide [95] on ma-
lignant glioma-derived cancer stem cell, doxorubicin (Dox) on human
glioma cell [96], breast cancer stem cells [15], human melanoma cell
line [97]; and to promote crossing the blood barrier, thereby facilitat-
ing greater accumulation of the drug in tumor cells [96].
In TERM field, the strategy of using NPs aims to administrate bi-
ological factors [98], drugs [99] and genetic materials [100] to the im-
planted cells inside a 3D scaffold in order to mimic the extracellular
matrix and enhance tissue regeneration [101]. In order to treat bone-re-
lated diseases, AuNPs have also been conjugated with bisphosphonate
for osteonecrosis [102] and with glycating agents (e.g. fructose and
bovine serum albumin) to inhibit the growth of bone cancer cell [103].
PEGylated AuNPs conjugated with a fragment of neural cell adhesion
molecule L1 led to enhance the intracellular delivery of the biomole-
cules. They also stimulated L1-mediated functions in murine primary
neurons and Schwann cells. The bioconjugates are thus a promising
tool for neuron regeneration after nervous system injury [104]. Like-
wise, PEGylayted AuNPs have been reported to be a favorable drug
delivery platform with therapeutic potential. Papstefanaki et al. have
administered PEG-AuNPs via intraspinal injection in mouse model af-
ter spinal cord injury, which led to promote hind limb motor recovery
in addition with a decrease of inflammatory response, enhancement of
motor neural survival and increase remyelination [105].
Compared to direct adsorption of the bioactive molecule on the
surface of an implanted scaffold, a carrier delivery system provides
controlled, long-term release with adequate efficacy [99]. Kumari et
al. have reported that the incorporation of the flower-like AuNPs in
glycolic acid grafted chitosan scaffolds allowed the control of drug
release of cysclophosphamide [106]. Contrary to the fast release of
the drug at the surface of the crude scaffold, the presence of the Au
nanoflower allowed decreasing the release rate of the carried drug.
Later on, they synthetized a hybrid scaffold composed of chitosan-g-
glycolic acid and Au–Fe3O4 NPs [107]. The composite have shown to
be more resistant to pH and to have a role in cell adhesion, prolifera-
tion and migration. Moreover, the presence of Au–Fe3O4 allowed the
decrease of drug release rate in PBS (pH 7.4).
The capacity of switch on/off the release of the drugs from en-
vironmental changes such as temperature, pH, light, and mechanical
stress directly to the cell is very attractive, in term of controlling the
rate and the dose of the released drug [108]. Recently, Kearney et
al. have reported a proof-of-principle for on-demand delivery of bone
morphogenetic protein-2 (BMP-2)-AuNPs into 3D microbeads algi-
nate scaffold using ultrasound [109]. Upon ultrasonic stimulation,
BMP-2 was released from AuNPs. The resulting supernatant was ad-
ministered to mMSCs, which led to twofold increase in alkaline phos-
phatase activity over osteogenic media controls. The authors claimed
that this approach can be regarded as an alternative to release in a pre-
cise fashion growth factor inside scaffolds.
Gene therapy, e.g. delivering biological molecules such as DNA
and siRNA to regulate cells behavior holds great promise for TERM,
but may be limited to intracellular entry of the oligonucleotides.
AuNPs have been used for gene delivery to enhance transfection ef-
ficiency, cell proliferation and differentiation [61]. Tencomnao et al.
have prepared gold/Cht/PEI nanoscaffolds as non-viral gene carrier,
on which Luciferase-encoding plasmid DNA were adsorbed [78]. The
resulting nanocomplex has shown higher transfection efficiency on a
human lung adenocarcinoma epithelial cell line (A549) and a human
cervical cancer cell line (HeLa) than polymeric-based carriers and can
be used as an alternative to viral gene delivery system.
Interestingly, the successful delivery of siRNA via AuNRs has pro-
voked the down-regulation of lysine-specific demethylase 1 (LSD1)
inducing the differentiation of human mesenchymal stem cells (hM-
SCs) [81]. Then, supplemented with hepatocyte growth factor, the
nanocarrier enhanced the differentiation of hMSCs into a hepato-
cyte lineage. All these studies highlight the importance of consider-
ing AuNPs as a carrier to deliver siRNA, DNA for tissue regeneration
treatment.
Another factor to be addressed is the interaction with complex tis-
sues (e.g. skin), which extend at larger scales than the cells. Fernan-
des et al. have investigated the effect of the penetration of AuNPs
through human and mouse skin depending on the morphology, charge
and function of the NPs [110]. They observed that positively charged
and rod-shape of AuNPs are favorable for the penetration of skin.
When functionalized with cell penetrating peptide, they are found in
the deeper layer of the skin. AuNPs hold promise as drug-delivery sys-
tems because of their ability to penetrate and interact with the skin.
3.1.2. AuNPs-based photothermal therapy
Despite the great achievement exploiting AuNPs-mediated pho-
tothermal therapy (PT) in cancer research, this concept is still at its in-
fancy in the field of TERM. However, we will discuss about this con-
cept and the new trends combining PT with others modalities since we
assume that in the near future PT-based tissue engineering strategies
will emerge. In this sense, we can mention the photorelease of PC-
miR-148b from silver NPs in order to modulate the osteogenic differ-
entiation of hASCs using light as a non-invasive triggering modality
[111].
Typically, PT is a non-invasive technique consisting on the de-
struction of cell through heat. Upon exposure to a laser beam, AuNPs
enable to absorb light and to convert it into heat with high efficacy
and thus this technique has been employed to locally destroy cancer
cells [112,113]. Various shapes of AuNPs such nanospheres [114],
nanorods [115], nanocages [116,117], nanoshells [118], and caged
gold nanorods [119] have been served on this purpose [120]. How-
ever, gold nanostructures with optical properties tunable in the near-
infrared region (650–900 nm) are particularly attractive for cancer
therapy. This optical window is considered to be the best spectral re-
gion, due the relatively low attenuation of blood and soft tissue al-
lowing deep penetration. On particularly, AuNRs have shown to be
very effective in eliminating malignant cancer cells related to brain
[115], breast [121,122], liver [123], and therefore represent an impor-
tant area of research for therapeutic development. Cabada et al. have
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reported a significant decrease of cell viability of glioblastoma after
20 min of laser irradiation in the presence of AuNRs, while no de-
crease in cell viability was observed with laser irradiation or incuba-
tion with AuNRs alone [115]. Likewise, Huang et al. have photo-ther-
mally and selectively killed two malignant cells, leaving the healthy
cells unaffected [124].
However, new therapeutic strategies are still under investigation in
order to achieve more efficient outcomes. Combining different ther-
apy modalities in a unique system, instead of using them individ-
ually, will allow enhancing their efficacy and reduce their side ef-
fects. Taking advantages of the ability of AuNPs to carry drugs, re-
searchers and clinicians have envisaged that heating the surfaces of the
NPs without measurably increasing the temperature of the surround-
ings offers as well the possibility of photo-release without killing
cells. Therefore, multimodal NPs combining both chemotherapy and
PT can have a significant clinical potential for the ablation of tumor
both in vitro and in vivo [125]. Wang et al. designed a multi-respon-
sive nanoplatform based on dox-loaded gold nanocages [126]. NIR
light irradiation have shown to enhance the release of Dox from the
NPs in cancer cells and dramatically improved the therapeutic effi-
ciency. Both in vitro and in vivo results demonstrated that the combi-
nation of PT and chemotherapy resulted in harsh cell toxicity, while
chemotherapy or PT treatment alone could not reached these effects
[127]. Very recently, methotrexate, an anti-rheumatic drugs, encapsu-
lated within poly(lactic-co-glycolic acid) PLGA NPs have been com
bined with gold NPs or gold nanoshells for chemo-phothermal treat-
ment of rheumatoid arthritis [128,129].
To push the barrier further, AuNRs have been, recently, designed
and multi-functionalized to synergistically combined chemotherapy,
hyperthermia and immunotherapy [130]. Doxorubicin,an anticancer
drug, and non-methylated cytosine–guanosine (CpG) oligodeoxynu-
cleotides,an immunostimulator, have both been attached to AuNRs
and simultaneously delivered to tumor tissue after irradiation (Fig.
5A). The engineering vehicle exhibited in vitro and in vivo signifi-
cant antitumor efficacy (Fig. 5B). Likewise, the doxorubicin release
from hollow AuNPs after NIR laser and radiation in murine tumor
xenograft model led to delay tumor growth by a factor 4.3 and re-
duce tumor weight by 6.8-fold compare to control tumors [131]. The
synergetic effect of cell therapy combined with PT has also been re-
ported. Recently, AuNRs have been loaded in tumor-tropic neural
stem cells (NSCs) in order to favor the removal of entire tumor mass
and to prevent the collateral damage to the surrounding healthy tis-
sue [132]. This innovative approach allowed increasing the concen-
tration of particles throughout tumor when carried by NSCs, as ev-
idenced by reduced recurrence rates of triple-negative breast cancer
(MDA-MB-231) xenografts following NIR exposure. This method
that showed improvement of efficacy AuNRs-loaded NSCs on as
compared to free AuNRs may be considered as a new generation for
cancer therapy.
Exploiting the PT-based cancer therapy concept, Adah Almutairi,
professor at the University San Diego have developed a system for
Fig. 5. (A) Schematic diagram of a co-delivery system based on gold nanorods to deliver doxorubicin and CpG ODNs. (B) Anti-tumor efficacy of the NIR-responsive NP platform.
(1) The volumetric changes in tumor size relative to that at day 0 are plotted over time (2) Changes with time in body weight achieved from mice. Reprinted from [130]. Copyright
2014, with permission from Elsevier
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fat removal using NPs-based liposuction [133], called «NanoLipo».
This technology relies on the selective and local heating of adipose
tissue upon external near-infrared laser exposure of AuNR allowing
the fat to be liquefied and easily aspirated. The study assessed in Yu-
catan mini pigs have demonstrated that NanoLipo facilitates removal
of twice as much fat and requires less time (4 vs 10 min) than conven-
tional suction assisted-lipectomy.
3.2. AuNPs-based stem cell labeling and tracking
The evaluation of differentiation and pluripotency of stem cells is
crucial and will help for a better understanding of how manipulate
stem cells in the area of TERM. The current methods used to detect
the differentiation status are based on the analysis of specific biomark-
ers related to the differentiated stem cells. Gene marker expression to
evaluate the differentiation mechanism is detected using polymerase
chain reaction (PCR). However, this cumbersome method required the
use of a large amount of cells. Therefore, there is a need to diag-
nose differentiated vs undifferentiated stem cells in an easy (fast and
user-friendly protocols), non-destructive, in situ and long-term ways
[134,135].
Due to their interesting absorption and scattering properties,
AuNPs have been widely used to detect macromolecules (e.g. proteins
[136], oligonucleotides [137,138]), cancer [139] and other diseases
[140], virus [141] and bacteria [142]. A variety of biosensing strate-
gies have been considered using AuNPs either as signal amplifier[143]
or as signal inducer [144]. Therefore, AuNPs may offer a multitude
of probe-target recognition-induced signal approaches to distinguish
stem cells in each stage of their differentiation process.
Surface-enhanced Raman spectroscopy (SERS) is a non-destruc-
tive technique used in the detection of chemical and biological com-
pounds and that has shown promising results to determine the status
of stem cells differentiation. In presence of AuNPs, the SERS signal
is enhanced, leading to an improvement of the sensitivity [143,145].
Kim et al. have used this technique in combination with a 3D graphene
oxide-encapsulated AuNPs (GO-Au) for the detection of the poten-
tial differentiation of neural stem cells (NSCs) [146]. The concept was
based on the fact that undifferentiated stem cells exhibit polyunsat-
urated membranes and unsaturated molecules that are rich in C
C bonds due to aromatic structures. Undifferentiated and differenti-
ated NSCs were analyzed using GO-Au-based SERS. The results have
shown that the Raman signals when the cell were non-differentiated
were more intense, enabling net discrimination between undifferen-
tiated/differentiated state of NSCs. Kuyen li et al. have developed a
multiplex approach for the detection of cell surface markers CD44 and
CD24 in three breast cancer lines [147]. Their design consisted on tar-
geting the markers through specific recognition with antibody-conju-
gated AuNPs (pointer). The SERS signal was enhanced upon the ad-
dition of (ss)DNA-conjugated AuNPs (enhancer), arising through hy-
bridization-mediated pointer-enhancer aggregation.
AuNPs can act as a signal inducer due to their optical properties,
which led to the development of multitude of colorimetric and im-
munoassays [148–150]. Distinction between different cell types in-
cluding 786-O (human kidney carcinoma cell line), L929 (murine ane-
uploid fibrosarcoma cell line), HeLa and RAW264.7 (macrophage cell
line) have occurred using enhanced nanoplasmonic effect of AuNPs
[139]. Lateral flow assays using AuNPs as optical molecular probes
have also been exploited as analytical method for the detection of
miRNA [151], food-borne pathogens [152], heavy metals [153]. This
technique based on competitive immunoassay provides a fast, easy
and on-site qualitative visual responses (yes/no result) of the pres-
ence of a target analyte for a wide range of medical, food, en
vironmental applications, and it is well-known as home pregnancy
test. By it turns, lateral flow immunosystems based on the double
antibody sandwich methods have been developed to detect human
pluripotent stem cells (hPSCs) [154]. The device allowed the detec-
tion of 1 × 104 cells within 20 min by the naked eyes and 7000 stem
cells with a portable strip reader. The response of the optimized LFB
was highly linear over a range of 1 × 104 to 2 × 105 human stem cells.
Later on, the same group has developed a nucleic acid lateral flow
to enhance hPSCs detection efficacy [155]. Firstly, magnetic beads
coated with antibody were used to enrich the target cells and the sec-
ondary antibody linked with an oligonucleotide was used as amplifi-
cation method. Then the oligonucleotide was amplified and detected
with the lateral flow biosensor (Fig. 6A). That strategy allowed de-
tecting a minimum of 100 hPSCs within 80 min time by naked eye
(Fig. 6B and C). The LFB can have important applications in the field
of regenerative medicine such as to determine the efficiency to stem
cell to differentiate in a specific lineage.
With the aim of detecting of live human mesenchymal stems cells
during their differentiation process, Choi et al. have exploiting the flu-
orescent quenching effect of AuNPs based on the fluorescence res-
onance energy transfer (FRET) [156]. Typically, fluorescent probes
are attached to the particles, which obstructs their fluorescence prop-
erties. Upon probe-target recognition, the fluorescent probes are re-
leased from AuNPs leading to a fluorescent signal. In their work,
they reported the differentiation status of hMSCs (i.e., differentiated
vs undifferentiated) via the detection of miRNAs in living stem cells
(Fig. 7A). In the differentiated status, specific miRNA such as
miR-29b and miR-31 are up-regulated during osteogenic differen-
tiation. Thus, heparin DNA strands (hpDNAs) that can recognize
these two osteogenic miRNAs markers, were attached to
dopamine@AuNPs (Au@PDA). Upon target miRNAs, hpDNAs was
dissociated from Au@PDA and recovered their fluorescence features.
The Au@PDA nanoprobe was internalized inside undifferentiated and
osteogenic differentiated hMSCs, and inside living primary osteoblast
and 3T3 fibroblasts. Fluorescence was detected when the cells pre-
sented osteoblast profiles (Fig. 7B). More importantly, their
nanoprobes provided long-term tracking of intracellular miRNAs in
living stem cells, which couldn ́t be achieved by commercially avail-
able RNA detection probe such as SmartFlare [156].
3.3. AuNPs-based cellular imaging
The imaging of cells proliferation, differentiation and tissue re-
generation [157,158] is crucial not only to determine morphological
structure and the localization of transplanted cells within the body
or inside scaffold but as well to evaluate how the cells respond and
interact to the microenvironment. To overcome the traditional inva-
sive techniques (e.g. immunohistochemistry, histochemistry), the new
emerging imaging techniques might have to be non-invasive, and ca-
pable of sensitive, quantitative, longitudinal assessment of cell be-
haviors with high spatial and temporal resolutions at sufficient depth.
Nowadays, dark-field microscopy [159], magnetic resonance imag-
ing [160,161], ultrasound imaging [162], two-photon luminescence
imaging [163], photoacoustic tomography [164], optical coherence to-
mography (OCT) [165] and X-ray computed tomography [166] have
been investigated individually or combined in nanomedicine, enabling
cells tracking. Due to their scattering and light absorption properties,
as well as their high photostability compared to traditional dyes or
semiconductor crystals, AuNPs have been used as contrast agent in
order to provide a better visualization and thus improve the perfor-
mance of such techniques [157], For example, 30 nM of AuNRs in-
jected to the anterior chamber of mice eyes have produced a contrast
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Fig. 6. (A) Schematic illustration of the LFB for the detection of human pluripotent stem cells (hPSCs). (1) Magnetic enrichment of hPSCs and DNa amplification. (2) The amplified
product is loaded onto the sample pad for visual detection. (B) Typical images of biosensor for hPSC detection with different amounts of iPSCs, ranging from 0 to 107 cells. (C)
Selectivity of biosensor for human pluripotent stem cell detection. Reprinted from [155]. Copyright 2015, with permission from Elsevier
signal 50% higher than the control with saline injection, making them
suitable to be used with OCT (Fig. 8A). Hence, AuNPs offer a great
potential for cell labeling, thus offering the opportunity to visualize
and track cell in vitro and in vivo.
Dark-field microscopy has been mainly used to evaluate cellular
uptake [167,168], cell migration [169], molecular affinity [170]. This
modality collects scattered light from a sample to show its scatter-
ing properties. The particles are excited by a broad white-light source,
but only light frequencies matching the LSPR are strongly scattered.
Thus, AuNPs are visualized as bright spots. Dark-field imaging has
been also used to determine the affinity of DNA-modified AuNPs with
different end group (e.g. NH3, PO3, OH, CH3 and SH) AuNPs to be
internalized in human hepatoma HepG2. The results have shown that
tuning surface functionality alters the internalization process, resulting
on a lower uptake of NPs with CH3 and SH groups. Boca et al. have
reported the high affinity of chitosan-gold NPs with Chinese hamster
ovary [168].
Photoacoustic (PA) imaging is a common modality in biomedicine
and is based on the detection of acoustic waves generated by ther-
mal expansion of tissue when exposed to laser pulse. AuNPs have
shown to be very promising as contrast for PA imaging due to their
strong light absorption properties. For example, silica-coated AuNRs
internalized in mesenchymal stem cells allowed the tracking of these
cells in living mice by enhancing the PA signal [71]. Likewise, gold
hallow nanospheres showed better contrast and clarity of the mouse
brain vascular image, than PA imaging without contrast [171]. Gold
nanocages have demonstrated to be a promising contrast agent for the
tracking of human mesenchymal stem cells using two-photon and PA
imaging modalities [172]. In another works, stem cells have been la-
beled with 20 nm AuNPs (nanotracers) to monitor the regenerative
process of mesenchymal stem cells [173,174] and adipose-derived
stem cells [175] in 3D PEGylated fibrin gel for vascular and der-
mal tissue engineering. Combining ultrasound (US) imaging with PA
imaging allowed to monitor MSCs after injection of rat muscle [174].
Firstly, AuNPs were internalized by MSCs, as confirmed by dark-
field microscopy. Subsequently, the labeled MSCs were cultured in
PEGylated fibrin gels and implanted at the ischemic region, followed
by US-guided PA imaging (Fig. 8B). The synergistic effect of the
both modalities provided information about the neovascularization
and MSCs distribution. While the MSCs without AuNPs did not pro-
duce any PA signal, gold-labeled MSCs were imaged over a 1-week
time period, which implies the possibility of longitudinal cell tracking
using PA imaging.
X-ray computed tomography is one of the leading radiological
technologies applied in the field of biomedical imaging. Cole et al.
have used bisphosphonate-functionalized gold nanoparticles (BP-
AuNPs) as radiographic contrast agent to detect breast microcalcifi-
cation in vitro and in ex vivo tissue model [176]. To mimic the het-
erogeneity of the breast tissue, different concentrations of hydrox-
yapatite in a Matrigel® carrier were injected into murine mammary
glands. The X-ray attenuation of HA-Matrigel compositions labeled
by BP-Au NPs was increased by up to 289 HU compared to unla-
beled compositions for HA concentrations ranging from 0.5 to 25 mg/
mL, which included an HA concentration (0.5 mg/mL) that was other-
wise undetectable by micro-computed tomography. In another study,
near-infrared fluorescent silica-coated AuNPs (Au@SiO2) in partner-
ship with a dual fluorescent/X-ray CT modal imaging system al-
lowed to provide anatomical information, including the location and
size of lymphs nodes (LNs) and lymphs vessel LVs for deciding
a surgery plan (Fig. 8C) [19]. In the axial CT images, the cervi-
cal LNs were localized and their size was determined around 2 mm,
which was in agreement with their actual size. Au@SiO2 ex
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Fig. 7. (A) Intracellular detection of miRNAs in living human Mesenchymal Stem Cells (hMSCs). (B) Monitoring of differentiation progress of hMSCs via the intracellular detection
of miRNAs. (1) Confocal images of hMSCs treated with nanoprobes targeting miR-29b (green). Scale bar is 100 μm. Inset: High-magnification images of the boxed area. Scale bar
is 25 μm. (B) Confocal images of hMSCs treated with nanoprobes targeting miR-31 (red). Scale bar is 100 μm . Reprinted with permission from[156]. Copyright 2015 American
Chemical Society. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
hibited a higher CT contrast than the Iopamiron, iodine-containing
molecule used as a CT contrast agent, at similar molar concentration,
which highlight then their promising use for CT.
The aforementioned techniques can profit from AuNPs, enabling
the location and the size of tissue that might be interesting to be used
when cells and scaffold are implanted within body to follow in real-
time tissue formation.
4. AuNPs in TERM strategies
4.1. AuNPs-based strategy to enhance stem cell differentiation for
bone tissue engineering
In the human system, the formation of bone tissue is induced
by osteogenic differentiation of mesenchymal stem cells towards os-
teoblasts. Subsequently, these cells synthetize and mineralize the col-
lagenous extracellular matrix of the bone. The strategy of bone tissue
engineering aims to promote the osteogenic differentiation and min
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Fig. 8. (A) 3D rendering of OCT image. Adapted from [18]. Copyright © 2014 Royal Australian and New Zealand College of Ophthalmologists(B) In vivo monitoring of gold nan-
otracer labeled MSCs using combined ultrasound and photoacoustic (US/PA) imaging. Adapted from [174]. Copyright © 2012 Nam et al (C) CT MIP images of a mouse injected
with Au@SiO2 NPs intradermally into the left paw: (A and B) pre-injection, (C and D) 18 h post-injection. Axial CT images of the mouse: (E and G) pre-injection and (F and H) 18 h
after injection . Adapted from[19]. Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
eralization capacity of different cell types such as stem cell, os-
teoblast-like or pre-osteoblast. Cultured in presence of osteogenic me-
dia, those cells differentiate in mature osteoblast, as assessed by a
high level of alkaline phosphate (ALP) and mineralization, two mak-
ers of osteogenesis, and by high level of gene expression. Table 2
summarizes the several studies reporting the possibility of AuNPs
to induce cell differentiation into osteogenic, adipogenic lineages
[177,173,178–185]. Recently, some reports have emerged pointing
out the ability of AuNPs to promote the differentiation of stem cells
into osteogenic lineage, making them a powerful system for bone re-
generation [177–179,183]. However, the cell proliferation, differenti-
ation and mineralized nodules formation have behaved differently de-
pending on the type of cells, size, surface composition and concen-
trations of AuNPs. Human adipose-stem cells treated with 1, 5 and
14 μg/mL of AuNPs differentiated in a dose-dependent manner.[178]
Liu et al. have investigated the size effect of AuNPs on the prolifera-
tion, differentiation and mineralization of a murine pre-osteoblast cell
line MC3T3-E1 [179]. After 7 and 14 days of in vitro culturing, the
ALP activity and the gene expressions Runx2, BMP-2, ALP and OCN
were increased in presence of the both type of particles, however bet-
ter results were observed with smaller particles. On contrary, human
adipose-derived stem cells differentiate faster when incubated with
30 nm and 50 nm AuNPs than the one treated with smaller (15 nm) or
bigger (75 and 100 nm) AuNPs. [183] Tsai et al. [180] reported that
10 nm AuNPs in MG63 osteoblast like cells doesn ́t have any signifi-
cant role in the osteogenic differentiation. The viability, specific nod-
ule-like phenotype and gene expression were similar to the control.
Various results on the osteogenic process have been reported and
a final conclusion of how AuNPs promote the bone formation still
remained unclear. Yi et al. [177] have reported that the internaliza-
tion of 20 nm AuNPs stimulate osteogenic differentiation in a dose-
dependent manner, as noticed by an increase of ALP and mineraliza-
tion quantification with higher AuNPs concentrations (Fig. 9A). It has
been suggested that the internalization of AuNPs may act as mechan-
ical stimuli of MSCs that activates p38 mitogen-activated protein ki-
nase (MAPK) pathway (Fig. 9B). On contrary, analogous assays using
adipose-inducer media have shown that AuNPs in this case inhibited
the adipogenic differentiation due to the down regulation of adipoge-
nesis specific genes. Recently, the surface composition of AuNPs al-
lowed the control of human bone marrow-derived mesenchymal stem
cells differentiation (Fig. 9C) [181]. Positively charged amine-modi-
fied AuNPs and neutral hydroxyl-modified AuNPs showed no specific
effect on the cell behavior, whereas negatively-charged carboxylic-
AuNPs hampered osteogenesis. When cells were treated with nega-
tive AuNPs, the ALP and calcium deposition were reduced, possibly
due to an upregulation of FGF-2 and TGG-β expression promoting
cell proliferation over osteogenic differentiation. We can also mention
that the presence of AuNPs is not always used to enhance cell dif-
ferentiation, in some cases having a great potential for use in osteo-
porosis therapy. Sul and co-workers have reported that AuNPs may
have a negative effect on the osteoclast formation of bone marrow de-
rived macrophages, stopping thus bone resorption [182]. The antiox-
idant nature of AuNPs prevented ROS production and the up-regu-
lation of glutathione peroxidase 1 (GPx-1), leading to the inhibition
of activation of nuclear factor-κB ligand (RANKL) involved in osteo-
clastogenesis process.
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Table 2.
Effect of AuNPs for osteogenic and adipogenic differentiation.
Surface
composition
Size
(nm)
Supplemented
concentration Cells type
Cultured
time (days) Observations Ref.
Citrate-AuNPs 20 1 nM
0.2 nM
0.1 nM
Pluripotent
progenitor
Mesenchymal
Stem cells
7, 10 & 14 Promote differentiation in a Dose- and time-dependent manner;
Mechanical stimuli on MSCs to activate MAPK signaling stimuli on MSCs
and induce preferential differentiation; inhibit adipocytic differentiation
[177]
Citrate-AuNPs 20
40
0.015 nM
0.03 nM
0.15 nM
Murine Pre-
osteoblast
cell line
MC3T3-E1
7 & 14 Promote proliferation, differentiation, mineralization and gene expression in
a Dose- and time-dependent manner; ALP activity and mineralization rate
treated with 20 nm were higher than the one of particles treated with 40 nm
[179]
Citrate-AuNPs 15, 30,
50, 75,
100
1 μM Human
adipose-
derived stem
cells
7, 14 &21 All sizes promoted the differentiation of the cells towards osteoblasts; 30 nm
& 50 nm exhibits the highest osteogenic differentiation rates; 50 nm GNPs
group expressed the highest ALP level, and mineralization formation
[183]
Citrate-AuNPs 10 1 pM
10 pM
MG63
osteoblast-
like cells
Cells were treated for 20 h
with AUNPs; and then
recultured for 21 days in
fresh medium w/o NPs
Have no specific effect on osteogenesis and apoptosis [180]
Amine
Caboxyl
Hydroxyl
Citrate
(control)
22
17
12
18
0.5 nM Human bone-
marrow-
derived
mesenchymal
stem cells
21 days Amine, hydroxyl and citrate AuNPs have no effect on osteogenesis; carboxyl
AuNPs reduce ALP activity and matrix mineralization and up-regulate
growth factors FGF-2 and TGG-β gene which could promote cells towards
proliferation as well as inhibiting ECM development
[181]
Citrate AuNPs
– embedded in
gelatin
hydrogel
scaffold
27 ± 3 1, 5 & 14 μg/
mL
Human-
adipose stem
cells
4, 7, 10 & 14 days Promote osteogenesis differentiation in dose & time dependent manner [178]
N/A 150 1 & 2 μg/mL Bone morrow
derived
macrophages
3 days Inhibition of osteoclast formation [182]
Citrate 13
45
Human
adipose-
derived
stromal cells
Reduce adipogenesis [184]
Citrate
Poly L lysine
20
40
60
Mesenchymal
Stem cells
Differentiate into adipogenic and osteogenic lineage as measured oil red O
staining and von kossa staining, respectively.
[173]
Gellan gum-
coated AuNRS
47 × 10 0.05 nM SaOS-2 21 days AuNRs-GG combined with osteogenic media enhanced by two fold the
mineralization capacity, as compared to cells exposed to osteogenic media
alone
[185]
4.2. AuNPs-based strategy to enhance scaffolds efficacy
4.2.1. AuNPs-based scaffolds for mechanical and cell adhesive
perspectives
The use of scaffold for the regeneration of various tissues (e.g.
nerve, cartilage, bone, and cardiac/skeletal muscle) is one of the lead-
ing research area in tissue engineering [5,186,2]. Scaffolds are bio-
materials synthetized with natural polymer (e.g. collagen, polysac-
charides, silk fibroin) or semisynthetic polymer (e.g. poly (ɛ-capro-
lactone, PCL) with the aim to mimic the extracellular matrix (ECM)
to enhance cell adhesion, migration, proliferation, differentiation,
thereby fostering cell function and tissue growth. The ideal mate-
rial should exhibit properties close to those present in natural tis-
sues: porous 3-D microstructure, biocompatibility, biodegradability at
a controlled rate, adequate cell attachment surface, among other [5].
However, researchers are still working on the development of the
next generation of scaffold. Due to some limitations such as lack
of adhesion sites, poor mechanical structures and lack of electrical
conductivity of scaffolds, it is necessary to enhance their structural
and mechanical properties. Recently, the incorporation of nanoscale
structure into tissue engineering scaffolds have been proposed to fa-
cilitate tissue regeneration [8] and may play a key role on affect-
ing the mechanical and adhesive properties of the material, inducing
tissue morphogenesis and directing cell self-assembly in 3D [187].
AuNPs have been incorporated to scaffolds and have shown promis
ing features to improve biomaterials mechanical properties [188,189]
as well as to promote cell proliferation and differentiation [178].
It also can improve the electrical communication between cardiac
cells [13]. Grant and colleagues have developed several scaffolds
[190–192] through the crosslinking between polyethylene terephtha-
late (PET) or collagen with AuNPs, in order to improve the materials
degradation rate, which is favorable after implantation, while main-
taining an open microstructure. Incorporating AuNPs in a porcine di-
aphragm resulted in a biocompatible tissue scaffold capable of pro-
moting cell attachment and proliferation while reducing free radicals
levels for wound healing [190].
PET meshes are being used as a scaffold implant for hernia re-
pair due to their good mechanical properties. With the purpose of im-
proving its biocompatibility, Whelove et al. have conjugated 20 nm
AuNPs to PET surface [192]. The hybrid materials compared to the
pristine one, showed better cell viability and proliferation of L929 fi-
broblasts with high concentration of particles, and better antimicro-
bial activity. AuNPs thus can act as free radical scavengers that allow
the decrease of ROS and shows surface repellence of Pseudomonas
aeruginosa bacteria that make the hybrids scaffold more potential for
implantable biomaterial. Later, the same group has reported that the
use of 23 nm AuNPs implied in the formation of collagen scaffold
allowed improving scaffolds properties while maintaining an open
microstructure. The hybrid materials have shown better resistance
against degradation when exposed to collagenase and an enhance-
ment of the biocompatibility. Moreover, with long-term analysis, cel
UN
CO
RR
EC
TE
D
PR
OO
F
14 Current Opinion in Solid State & Materials Science xxx (2016) xxx-xxx
Fig. 9. (A): (1) Effects of AuNPs on the ALP activity of MSCs. (2) Effects of AuNPs on the mineralized nodule formation of MSCs. (B) Molecular mechanism of the modulation
of osteogenic and adipocytic differentiation of MSCs by AuNPs through p38 MAPK signaling pathway. Reprinted with permission from [177]. Copyright 2010 American Chemical
Society. (C) Alkaline phosphatase (ALP) activity and matrix mineralization after treatment with AuNPs in osteogenic induction medium for 21 days. (1) ALP staining and Alizarin
Red S staining. (2) ALP activity assay. (3) Quantification of ARS staining matrix mineralization per well. Adapted from [181], Copyright (2015), with permission from Elsevier.
lular retention, cell proliferation and GAG production were enhanced
over the pristine scaffold. The decrease of ROS production was also
observed, demonstrating the antioxidant properties of AuNPs that
might influence inflammation issue in vivo.
After a heart attack, cardiomyocytes, electrically responsive cells,
are cultured within a porous scaffold to grow and assemble into car-
diac tissues. However, because of the poor conductivity of biomate-
rials, engineering a scaffold that generates electrical stimuli is attrac-
tive in order to improve electrical communication between adjacent
cardiac cells [13]. In order to address this issue, some groups have in-
corporated AuNPs, because of their electrical properties, within poly-
meric scaffold. For example, You et al. have prepared a hybrid hy-
drogel scaffold composed of AuNPs and polymeric gel [193]. Car-
diac cells, seeded in the hybrid scaffold, exhibited increased expres-
sion of connexin 43 (Cx43), a protein located between cardiac cells
and responsible for electrical signal transfer. Likewise, Dvir ́s group
has reported several works incorporated gold compounds within three-
dimensional cardiac patches such as alginate [194], coiled PCL fiber
[195], PCL-gelatin fibrous [196] and decellularized matrices [197]
in order to promote cardiac cell-cell interactions, and therefore en-
hance the formation of cardiac tissue. Shevach et al. reported that the
presence of AuNPs allowed the cells to assembled into a more elon-
gated and aligned tissues, enhancing the overall contractility of the
engineered tissue [196]. The AuNPs on the PCL-gelatin fibers were
able to maintain the ratio of cardiomyocytes to fibroblasts in the cul-
ture, to encourage the growth of cardiomyocytes with significantly
higher aspect ratio, and promote massive cardiac sarcomeric actinin
expression. Finally, engineering cardiac tissues within AuNPs-based
scaffolds exhibited significantly higher contraction amplitudes and
rates, as compared to nude scaffolds [196,197]. Recently, the same
group developed a new nanocomposite scaffold, incorporating AuNPs
within coiled electrospun fibers (Fig. 10). Cardiac cells cultured
within the hybrid scaffold exhibited an aligned and elongated mor-
phology resembling to the natural morphology of cell bundles in the
myocardium [195]. Ravichandran et al. used AuNPs as a crosslinker to
stabilize BSA during the preparation of BSA/PVA nanofibers [198].
The presence of AuNPs results on favorable elastic properties of the
scaffolds for cardiac tissue regeneration. Then, the combination of
AuNPs-loaded nanofibers with 5-azacytidine, a molecule used to in-
duce cardiac differentiation, can enhance the cardiomyogenic differ-
entiation of MSCs, highlighted by an increase of cardiac proteins (ac-
tinin, troponin-T and Cx43) expression.
These findings thus emphasize the capability of AuNPs to serve for
the development of novel scaffolding strategies.
4.2.2. AuNPs-based nanosurface topography
In living systems, cells behavior is greatly influenced by the nanos-
tructured features of the extra-cellular matrix (ECM) component,
which should also be the case in TERM. One approach consists on
providing nanotopographical cues, with similar effect to that for
growth factors, in order to guide cell orientation. To mimic the struc-
ture and length scale of natural ECM, nanopatterned surfaces have be-
come rapidly under investigation [199], enabling to control cell mor-
phology, alignment, adhesion, differentiation and cytoskeleton orga-
nization. For example, osteogenic differentiation of stem cells has
been improved using engineered surface without [200–202] or in syn-
ergy with osteogenic inducers [203]. Diverse techniques, including
electron-beam lithography [204], photopatterning [205], soft-lith
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Fig. 10. (A) Schema representing the process of coiled fiber scaffold with incorporation of AuNPs; (B) Native and synthetic coiled fibers. (A) SEM image of the coiled fibers in a
decellularized heart. (B) ESEM image of an electrospun coiled fiber embedded with AuNPs. (C and D) SEM images of coiled fiber scaffolds. (E) ESEM image of the AuNPs embed-
ded on the synthetic fiber. (F) EDX spectrum of AuNP coiled fibers. Bars: (A), (B) and (D) – 20 mm, (C) – 50 mm, and (E) – 250 nm; (C) Cardiac tissue organization and function.
(A and B) Cardiac sarcomeric actinin immunostaining on day 7. Actinin – pink, nuclei – blue. (A) Cardiac tissue engineered within pristine scaffolds. (B) Cardiac tissue engineered
within AuNP scaffolds. (C) Cardiomyocyte area on day 3 and 7. (D) Cardiomyocyte aspect ratio on days 3 and 7. (E–G) Engineered tissue function. (E) Contraction rate on day
7. (F) Longitude change of the cell constructs on day 7. (G) Excitation threshold on day 7. Bars: left and right figures – 50 mm and 20 mm, respectively. Adapted from [195] with
permission of the Royal Society of Chemistry. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
ography [206], nanoimprint lithography [202], have been employed
for the development of artificial ECM-based structures.
However, some limitations such poor cell adhesion and cell-sur-
face interactions needs still to be solved. To enhance the efficacy of
patterned substrate, AuNPs can be used to control cellular alignment
on artificial surfaces. AuNRs have been aligned onto a glass tube via
flow assembly to guide the orientation and differentiation of myoblast
cells [207]. It has been reported that the height and spatial distance be-
tween of AuNPs may affect cell behavior [208]. Three different sizes
of NPs (16, 38, 68 nm) with a gradient of NPs density have been de-
posited onto a substrate. The 16 nm AuNPs enhanced cell adhesion
and number of 3T3 fibroblast and MG63 osteoblast cells than flat sub-
strate, with the best results with a surface density of 50 and 140 parti-
cles per μm2.
Moreover, prevention of nonspecific adsorption of proteins cou-
pled with adhesion of cells on surfaces is crucial for tissue engineered
scaffolding applications. By it turns, Rotello ́s group has investigated
the cell behavior of mouse embryonic fibroblast cells NIH3T3 onto
charged and uncharged AuNPs-deposited polyethylene imine (PEI)
substrate [209]. Their findings have demonstrated that the presence of
AuNPs decreased protein adsorption and improved cell adhesion and
viability, compared to PEI substrate. In addition, patterned PEI lines
(300 nm wide, 100 nm high) on surface via nanoimprint lithography
encouraged cells alignment. Moreover, the immobilization of nega-
tively charged AuNPs on the surface of PEI lines provided a higher
degree of cellular alignment and evenly spread NIH3T3 cell growth
in the direction of the patterns. This behavior can be explained due to
the non-fouling properties of the AuNPs coated surfaces and effective
communication between the surface and the cells.
In the concept of TERM, cells guidance nanotopography needs to
be extended/adapted to more challenging 3D structures. Thus, AuNPs
have been incorporated in 3D silk electrospun nanofiber matrix (SNF)
and then functionalized with specifically an integrin-binding cell ad-
hesive peptide, arginine-glycineaspartic acid motif (RGD) [188]. The
presence of AuNPs within SNF and SNF-RGD allowed to
increase cellular spreading, cell adhesion and cell density compared
their respective controls (SNF and RGD-SNF).
5. Final remarks, future trends and challenges
AuNPs represent a promising tool for TERM. They are particu-
larly advantageous since they are able to deliver bioactive molecule, to
diagnose stem cell differentiation status and to track implanted cells,
while enhancing stem cell differentiation, adhesive and mechanical
properties of scaffolds, and cell-cell interactions. However, AuNPs-
mediated tissue engineering strategies still represent a great challenge.
Some questions may be raised and definitely needs to be answered
before eventual translation to clinical applications. The unreliable re-
sults related to the interaction between cell and AuNPs have to be
definitely clarified. Whereas it has been stipulating that AuNPs con-
tributed to higher production of ROS, which is unbeneficial for cells,
more recently it was reported that ROS production is decreased when
AuNPs are incorporated within scaffolds. In addition, it has been
discussed that AuNPs can stimulate osteogenesis differentiation of
stem cells, while inhibiting adipogenic differentiation. And thus, it
is difficult to prognostic how the cells will respond in contact with
AuNPs. The future trends are thus now to combine all required in
vivo and in vitro assays in a long-term study to be able to end up
with standardized protocols , e.g. defining appropriate cell type, op-
timized AuNPs dose, and relevant cytotoxicity assays. Moreover, re-
cently there is a huge effort to develop 3D artificial vascularized tis-
sue in cancer research in order to recreate the human tissue environ-
ment. Thus, as an alternative to 2D culture and animals, this approach
have a great potential to determine and really understand what hap-
pen and what will happen in the body when the cells are cultured
with AuNPs. In addition, this new strategy might give more informa-
tion regarding the biodistribution and elimination of AuNPs from the
body (process still poorly understood). There is no doubt of the po-
tential of using AuNPs in nanomedicine, as suggested by the on-go-
ing clinical trials for AuNPs-based cancer therapy system such as Au
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rImmuneTM and AuroShellTM. In addition, with the great interest of
using AuNPs in nanomedicine, most of these challenges will continue
to be addressed in the upcoming research studies.
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